Journal
DERMATOLOGIC THERAPY
Volume 34, Issue 3, Pages -Publisher
WILEY
DOI: 10.1111/dth.14931
Keywords
biologic drugs; biologics; pregnancy; psoriasis
Categories
Ask authors/readers for more resources
The lack of safety data on pregnant women makes it difficult to choose the correct biologic agent for treating psoriasis in women of childbearing potential. Studies have suggested a potential role of IL-23 in unexplained recurrent spontaneous abortions, leading to considerations about using anti-IL-23 drugs in the treatment of psoriasis in women of childbearing potential.
Lack of safety data on pregnant women determines difficulty in choosing the correct biologic agent to treat psoriasis in women of childbearing potential. Studies have postulated a role of IL-23 in unexplained recurrent spontaneous abortions. This gives rise to consideration about use of anti-IL-23 drugs in treatment of psoriasis in women of childbearing potential.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
